Literature DB >> 24913418

Strict rules are needed for validation of G-protein-coupled receptor immunohistochemical studies in human tissues.

Jean Claude Reubi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24913418     DOI： 10.1007/s12020-014-0320-0

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  13 in total

1.  Unspecific labeling of pancreatic islets by antisera against fibroblast growth factors and their receptors.

Authors:  Darwin S Dichmann; Claude Rescan; Ulrik Frandsen; Palle Serup
Journal:  J Histochem Cytochem       Date:  2003-03       Impact factor: 2.479

Review 2.  A guide to the perplexed on the specificity of antibodies.

Authors:  Clifford B Saper
Journal:  J Histochem Cytochem       Date:  2008-10-14       Impact factor: 2.479

3.  How reliable are G-protein-coupled receptor antibodies?

Authors:  Martin C Michel; Thomas Wieland; Gozoh Tsujimoto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-01-27       Impact factor: 3.000

4.  The glucagon-like peptide-1 receptor--or not?

Authors:  Charles Pyke; Lotte Bjerre Knudsen
Journal:  Endocrinology       Date:  2013-01       Impact factor: 4.736

5.  Editorial: antibody validation requirements for articles published in endocrinology.

Authors:  Andrea C Gore
Journal:  Endocrinology       Date:  2013-02       Impact factor: 4.736

6.  Internalized somatostatin receptor subtype 2 in neuroendocrine tumors of octreotide-treated patients.

Authors:  Jean Claude Reubi; Beatrice Waser; Renzo Cescato; Beat Gloor; Christoph Stettler; Emanuel Christ
Journal:  J Clin Endocrinol Metab       Date:  2010-03-12       Impact factor: 5.958

7.  Somatostatin receptor subtype 2A immunohistochemistry using a new monoclonal antibody selects tumors suitable for in vivo somatostatin receptor targeting.

Authors:  Meike Körner; Beatrice Waser; Agnes Schonbrunn; Aurel Perren; Jean Claude Reubi
Journal:  Am J Surg Pathol       Date:  2012-02       Impact factor: 6.394

8.  Highly efficient in vivo agonist-induced internalization of sst2 receptors in somatostatin target tissues.

Authors:  Bea Waser; Maria-Luisa Tamma; Renzo Cescato; Helmut R Maecke; Jean Claude Reubi
Journal:  J Nucl Med       Date:  2009-05-14       Impact factor: 10.057

9.  The expression and actions of androgen receptor in upper urinary tract urothelial carcinoma (UUTUC) tissues and the primary cultured cells.

Authors:  Chih-Rong Shyr; Chi-Cheng Chen; Teng-Fu Hsieh; Chao-Hsiang Chang; Wen-Lung Ma; Shuyuan Yeh; Edward Messing; Tsung-Heng Li; Fu-Yin Li; Chawnshang Chang
Journal:  Endocrine       Date:  2012-08-01       Impact factor: 3.633

Review 10.  Incretin action in the pancreas: potential promise, possible perils, and pathological pitfalls.

Authors:  Daniel J Drucker
Journal:  Diabetes       Date:  2013-07-01       Impact factor: 9.461
View more
  3 in total

1.  Expression of neurotensin receptor-1 (NTS1) in primary breast tumors, cellular distribution, and association with clinical and biological factors.

Authors:  Clément Morgat; Véronique Brouste; Adrien Chastel; Valérie Vélasco; Gaétan Macgrogan; Elif Hindié
Journal:  Breast Cancer Res Treat       Date:  2021-10-01       Impact factor: 4.872

2.  Immunohistochemical Expression of Somatostatin Receptor Subtypes in a Panel of Neuroendocrine Neoplasias.

Authors:  Satu M Remes; Helena L Leijon; Tiina J Vesterinen; Johanna T Arola; Caj H Haglund
Journal:  J Histochem Cytochem       Date:  2019-06-10       Impact factor: 2.479

3.  Towards understanding leydigioma: do G protein-coupled estrogen receptor and peroxisome proliferator-activated receptor regulate lipid metabolism and steroidogenesis in Leydig cell tumors?

Authors:  M Kotula-Balak; E Gorowska-Wojtowicz; A Milon; P Pawlicki; W Tworzydlo; B J Płachno; I Krakowska; A Hejmej; J K Wolski; B Bilinska
Journal:  Protoplasma       Date:  2020-03-16       Impact factor: 3.356
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.